Showing results (391-400 of 533) with videos related to

Sort By:
Pageof 54
Journal of Medicinal Chemistry|May 26, 2021
Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/NatriureticJinlong Jiang, Fa-Xiang Ding, Xiaoyan Zhou, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Nature Communications|April 21, 2023
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriersLogan Brase, Shih-Feng You, Ricardo D'Oliveira Albanus, et al.
Brain : a Journal of Neurology|August 4, 2022
Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespanJingqin Luo, Folasade Agboola, Elizabeth Grant, et al.
EMBO Molecular Medicine|November 29, 2018
CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive declineMarc Suárez-Calvet, Anja Capell, Miguel Ángel Araque Caballero, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 24, 2025
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's diseaseValentina R Garbarino, Juan Pablo Palavicini, Justin Melendez, et al.
Pageof 54